This is a StreetInsider.com Premium Only Page

(MKKGY) – Management Comments

Sep 20, 2019 08:11 AM Merck KGaA, Pfizer (PFE) Announce CHMP Adopts Positive Opinion for BAVENCIO Plus Axitinib for First-Line Treatment of Patients with Advanced RCC

Feb 11, 2019 05:45 PM EMD Seron, Pfizer (PFE) Announce FDA Accepted sBLA and Granted Priority Review for BAVENCIO Plus INLYTA for Treatment of Advanced RCC

Jan 24, 2019 08:04 AM

Feb 15, 2018 08:45 AM

Nov 28, 2017 08:04 AM

Sep 21, 2017 06:23 AM